21.32
Catalyst Pharmaceuticals Inc Aktie (CPRX) Neueste Nachrichten
Catalyst Pharmaceuticals Inc (CPRX) Q3 2025 Earnings Report Prev - GuruFocus
Catalyst Pharmaceuticals Inc (CPRX) Q3 2025 Earnings Report Preview: What To Look For - Yahoo Finance
Will Catalyst Pharmaceuticals Inc. (CN2) stock keep high P E multiplesJuly 2025 Spike Watch & Expert Approved Momentum Trade Ideas - newser.com
Hussman Strategic Advisors Inc. Purchases 63,000 Shares of Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
What risks investors should watch in Catalyst Pharmaceuticals Inc. stockPortfolio Risk Summary & Fast Gaining Stock Strategy Reports - newser.com
Momentum divergence signals in Catalyst Pharmaceuticals Inc. chartEarnings Growth Report & Technical Pattern Recognition Alerts - newser.com
Relative strength of Catalyst Pharmaceuticals Inc. in sector analysis2025 EndofYear Setup & Expert Verified Movement Alerts - newser.com
Will Catalyst Pharmaceuticals Inc. stock split again soonJuly 2025 Spike Watch & Risk Controlled Daily Trade Plans - newser.com
Fünfjahresdaten zu AGAMREE® (Vamorolon) bei Patienten mit DMD zeigen ein verbessertes Sicherheitsprofil bei vergleichbarer Wirksamkeit wie bei der Standardbehandlung mit Kortikosteroiden - GlobeNewswire Inc.
Using Bollinger Bands to evaluate Catalyst Pharmaceuticals Inc.2025 Major Catalysts & Reliable Entry Point Trade Alerts - newser.com
Using portfolio simulators with Catalyst Pharmaceuticals Inc. included2025 Historical Comparison & Risk Controlled Daily Plans - newser.com
Why global investors buy Catalyst Pharmaceuticals Inc. (CN2) stockWeekly Risk Report & Free AI Powered Buy and Sell Recommendations - newser.com
Catalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference - The Manila Times
Is Catalyst Pharmaceuticals Inc. (CN2) stock a buy on weakness2025 Momentum Check & Risk Adjusted Swing Trade Ideas - newser.com
Applying Elliott Wave Theory to Catalyst Pharmaceuticals Inc.Quarterly Portfolio Report & Expert Curated Trade Setups - newser.com
Catalyst Pharmaceuticals (CPRX): Exploring Valuation as Shares Remain Steady and Investors Weigh Long-Term Growth - Yahoo Finance
Can Catalyst Pharmaceuticals Inc. hit a new high this monthEarnings Overview Report & High Return Stock Watch Alerts - newser.com
What analyst consensus says on Catalyst Pharmaceuticals Inc. stockJuly 2025 Price Swings & Daily Chart Pattern Signal Reports - newser.com
Catalyst Pharmaceuticals, Inc. $CPRX Shares Sold by State of New Jersey Common Pension Fund D - MarketBeat
Is Catalyst Pharmaceuticals Inc. (CN2) stock attractive post correctionPortfolio Growth Summary & Risk Managed Investment Signals - newser.com
Catalyst Pharmaceuticals Inc. recovery potential after sell offWeekly Trade Report & Entry Point Confirmation Alerts - newser.com
Price momentum metrics for Catalyst Pharmaceuticals Inc. explainedIndex Update & Technical Pattern Based Buy Signals - newser.com
Catalyst Pharmaceuticals, Inc. $CPRX Shares Sold by Moody Aldrich Partners LLC - MarketBeat
Will Catalyst Pharmaceuticals Inc. (CN2) stock sustain uptrend momentumBuy Signal & Community Verified Watchlist Alerts - newser.com
Is Catalyst Pharmaceuticals Inc. stock bottoming outWeekly Stock Recap & Low Risk Entry Point Guides - newser.com
Can Catalyst Pharmaceuticals Inc. (CN2) stock surprise with quarterly resultsAnalyst Downgrade & Stock Portfolio Risk Control - newser.com
How rising interest rates impact Catalyst Pharmaceuticals Inc. stockPortfolio Update Summary & Safe Capital Investment Plans - newser.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):